Table 3.

Summary of study outcomes.

References	Interventions	Sample size (N)	Outcomes * (baseline vs. final visit)
			ALT (U/L)	AST (U/L)	TG (mg/dL)	HDL-C (mg/dL)	BMI (kg/m 2 )
Fard et al. (18)	Usual care + telephone	30	80.30 ± 38.59 vs. 36.60 ± 19.27	46.83 ± 17.64 vs. 28.80 ± 9.85	NA	NA	28.8 ± 4.32 vs. 26.36 ± 3.95
	Usual care	30	63.52 ± 23.67 vs. 65.03 ± 28.68	38.52 ± 12.90 vs. 39.79 ± 15.33	NA	NA	28.5 ± 4.28 vs. 27.92 ± 4.19
Axley et al. (19)	Usual care +text messages	13	44 ± 6 vs. 32 ± 3	46 ± 6 vs. 37 ± 4	184 ± 34 vs.167 ± 35	40 ± 4 vs. 38 ± 4	39 ± 2 vs. 38 ± 3
	Usual care	17	57 ± 12 vs. 51 ± 11	47 ± 7 vs. 47 ± 8	194 ± 37 vs. 153 ± 25	40 ± 3 vs. 40 ± 3	36 ± 2 vs. 37 ± 2
Vilar-Gomez et al. (20)	Usual care + interventions	157	39.2 ± 25.4 vs. 25.8 ± 15.4	28.5 ± 17.6 vs. 20.7 ± 8.5	196.3 ± 120.2vs. 152.8 ± 130.6	43.2 ± 13.8 vs. 49.9 ± 16.5	39.4 ± 7.2 vs. 34.3 ± 6.5
	Usual care	38	40.7 ± 23.4 vs. 38.6 ± 24.9	32.7 ± 26.1 vs. 30.7 ± 20.5	197.4 ± 100.5vs. 214.2 ± 149.8	41 ± 11.3 vs. 37.2 ± 11.4	37.6 ± 6.9 vs. 38.2 ± 8.2

ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; NA, not available; TG, triglyceride.

^*Values are presented as mean ± standard deviation.